Thus, the Perioperative chemotherapy versus surveillance in upper Tract urothelial cancer (POUT) trial revealed a significant improvement in DFS, MFS, and DSS with a favorable trend in OS for adjuvant chemotherapy in locally advanced UTUC.
← all excerpts
The grimacing face of adverse upper tract urothelial carcinoma can now POUT with adjuvant chemotherapy!
1
—
—